Agilent Technologies, Inc. (NYSE:A)

mergers are not over-reaching, yet strengthen market share.

I don't know... I don't really know how this works...

agilent
no div
Total Debt / Equity    0.52
Price Earnings    13.10
Price/Sales    2.01
Price/Book    3.10
Price/Cash Flow    10.20

Increasing sales and margins screen. (master list).

I think it will outperform mainly because of the greater line of products and the requirements for safety in the foodchain. enviromental and new drugs research,.

Chemistry is the science of the 21st century.

we always need scientific instruments like mass spec

very highly rated by Zacks, IBD and Schwab, highly rated by Navelleir and looks good to me as a safe and steady buy & hold through the next uncertain 5 years.

A   SULLIVAN WILLIAM P   President and CEO   May 27   Sale   49.34   338,673   16,711,520   316,988   

A silent runner

The companies free cash flow has increased and it's in a sector that the road is clear for a stron move to the upside

Agilent is a spin-off of Hewlett Packard. They deal primarily with measurement, testing and analysis. These areas are becoming more and more critical.

hi all, as an experiment i have selected all [20] single letter stocks and during selection i got the feeling this may perform better then i thought in the first place...lets see where this gets me ;o)

Have never lived up to the HP legacy. Senior management are over-payed, bereft of vision and short-term focused. Under CEO Bill Sullivan's "leadership" the stock has grown zippy-do-diddly-squat since the $35 IPO 10 years ago. They've never known how to handle their cash cow EMG business and seem poised to sell it off. This will leave them with the more sexy higher-growth LSCA, but sadly their is nothing to suggest they won't screw that up as well.

Biotechs are my friend

test caps pitch

In your article "Is Agilent Technologies Worth Another Look?" you compared it to other companies such as Dolby Laboratories and Itron. These companies beat Agilent in most of the comparison criteria you listed. This was a terribly flawed comparison since these companies cover less then a third of the industries Agilent technologies covers. Half of Agilent's revenue comes from their electronic test and measurement group (EMG). This industry was hit hard by the downturn, but is making a strong comeback with devices like smartphones becoming incredibly popular. The companies you compared Agilent to do not have any portfolio in the electronic test measurement industry so they did not suffer in the downturn as much as Agilent. As the wireless and semiconductor industry make a comeback these next couple years, Agilent will take in a lot of revenue and profit that will allow it to aggressively grow, through acquisitions, into adjacent high growth industries.

test

fool